Cita APA

Yao, H., Wei, S., Xiang, Y., Wu, Z., Liu, W., Wang, B., . . . Gao, Y. (2019). Kangfuxin Oral Liquid Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1/Smad Pathway. Evid Based Complement Alternat Med.

Chicago Style Citation

Yao, Huan, et al. "Kangfuxin Oral Liquid Attenuates Bleomycin-Induced Pulmonary Fibrosis Via the TGF-β1/Smad Pathway." Evid Based Complement Alternat Med 2019.

Cita MLA

Yao, Huan, et al. "Kangfuxin Oral Liquid Attenuates Bleomycin-Induced Pulmonary Fibrosis Via the TGF-β1/Smad Pathway." Evid Based Complement Alternat Med 2019.